2020 Clinical practice guidelines for Chronic heart failure

2020 Clinical practice guidelines for Chronic heart failure

Endorsed by the Research and Practical Council of the Ministry of Health of the Russian Federation.

Saved in:

Bibliographic Details
Main Author:	. Russian Society of Cardiology (RSC)
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2020-12-01
Series:	Российский кардиологический журнал
Subjects:	chronic heart failure natriuretic peptides left ventricular ejection fraction diagnostics medical therapy non-drug therapy comorbidity decompensation hospitalization quality criteria guidelines
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/4083
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

2024 Clinical practice guidelines for Chronic heart failure
by: A. S. Galyavich, et al.
Published: (2024-12-01)

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)
by: S. N. Tereshchenko, et al.
Published: (2020-09-01)

Eurasian Association of Cardiology (EAC)/ National Society of Heart Failure And Myocardial Disease (NSHFMD) guidelines for the diagnosis and treatment of chronic heart failure (2024)
by: S. N. Tereshchenko, et al.
Published: (2024-05-01)

Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)

2020 Clinical practice guidelines for Stable coronary artery disease
by: . Russian Society of Cardiology (RSC)
Published: (2020-12-01)

Supramolecular complex sacubitril/valsartan - the first representative of a new class of drugs for the treatment of chronic heart failure
by: T. V. Ashcheulova, et al.
Published: (2019-12-01)

2020 Clinical practice guidelines for Acute ST-segment elevation myocardial infarction
by: (RSC) Russian Society of Cardiology
Published: (2020-12-01)

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
by: Th. McDonagh, et al.
Published: (2023-02-01)

CORRELATION BETWEEN VAS OPRESSIN CONCENTRATION AND CHRONIC HEART FAILURE SEVE RITY: CHARAC TERISTICS OF PA TIENTS WITH TERMINAL AND DECOMPE NSA TED HEART FAILURE
by: E. S. Trofimov, et al.
Published: (2018-07-01)

Natriuretic peptides and chronic heart failure in arterial hypertension patients
by: Yu. A. Vasuyk, et al.
Published: (2007-04-01)

In‐Hospital or Out‐of‐Hospital Initiation of Sacubitril/Valsartan Versus Valsartan in Patients With Mildly Reduced or Preserved Ejection Fraction After A Worsening Heart Failure Event: The PARAGLIDE‐HF Trial
by: Nina Nouhravesh, et al.
Published: (2025-03-01)

2016 ESC GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ACUTE AND CHRONIC HEART FAILURE
by: Piotr Ponikowski, et al.
Published: (2017-02-01)

Up‐titration of medication in patients with new‐onset heart failure with and without atrial fibrillation
by: Arietje J.L. Zandijk, et al.
Published: (2025-06-01)

Phenotypic clusters and biomarkers profile in patients with chronic heart failure with preserved and mildly reduced left ventricular ejection fraction
by: Natalia A. Dragomiretskaya, et al.
Published: (2024-12-01)

Potential of valsartan+sacubitril therapy in hypertensive heart disease
by: A. G. Ovchinnikov, et al.
Published: (2021-08-01)

Current diagnostic algorithms for chronic heart failure with preserved left ventricular ejection fraction
by: Ya. Yu. Maistrovych, et al.
Published: (2023-03-01)

Left ventricular global function index: prognostic value in patients with heart failure aged 60 years and older
by: V. N. Larina, et al.
Published: (2020-11-01)

Effect of immunomodulation on cardiac remodelling and outcomes in heart failure: a quantitative synthesis of the literature
by: Navkaranbir S. Bajaj, et al.
Published: (2020-06-01)

Gamma-glutamyl transpeptidase is a promising biological marker of heart failure
by: A. M. Alieva, et al.
Published: (2022-07-01)

Twenty-four-year-old patient with heart failure after myocarditis. Results of quadruple therapy: a case report
by: V. N. Larina, et al.
Published: (2023-04-01)

LEVOSIMENDAN IN PREOPERATION THERAPY FOR CARDIOSURGERY IN PATIENTS WITH CHRONIC HEART FAILURE
by: M. A. Babaev, et al.
Published: (2017-03-01)

Different Modes of Monitoring and Correction of Cardiac Function During Operations Under Extracorporeal Circulation
by: L. A. Krichevsky, et al.
Published: (2007-02-01)

Microcirculation in heart failure: state of the art (literature review)
by: I. M. Davidovich, et al.
Published: (2025-02-01)

Adherence to treatment as an integral component of the management of patients with heart failure
by: V. N. Larina, et al.
Published: (2024-02-01)

Incidence and determinants of left ventricular ejection fraction (LVEF) recovery in heart failure with reduced ejection fraction (HFrEF) of non-ischemic aetiology; a hospital-based prospective longitudinal registry study
by: Sanjeev Kumar, et al.
Published: (2025-05-01)

Prognostic value of myocardial flow reserve in patients with heart failure with preserved ejection fraction
by: K. V. Kopeva, et al.
Published: (2023-04-01)

Point-of-care N-terminal pro-brain natriuretic peptide testing in patients with heart failure: data from the DREAM study
by: F. I. Belyalov, et al.
Published: (2024-06-01)

Assessment of prevalence and monitoring of outcomes in patients with heart failure in Russia
by: E. V. Shlyakhto, et al.
Published: (2020-12-01)

Risk factors and diagnostic significance of the N-terminal pro-brain natriuretic peptide as a marker in patients with acute decompensated heart failure and diabetic kidney disease
by: N. A. Koziolova, et al.
Published: (2021-04-01)

ALGORITHM FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTION
by: E. V. Reznik, et al.
Published: (2018-03-01)

The role of brain natriuretic peptide and NT- probrain natriuretic peptide in diagnostics of chronic heart failure and asymptomaticleft ventricular dysfunction in patients with type 2 diabetes mellitus
by: Irina Arkad'evna Bondar', et al.
Published: (2011-09-01)

Cardiorenal relationships in patients with chronic heart failure with preserved ejection fraction
by: Yu. N. Panina, et al.
Published: (2023-11-01)

Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I
by: Yu. M. Lopatin, et al.
Published: (2021-05-01)

Acute on chronic heart failure—Which variations on B‐type natriuretic peptide levels?
by: Paulo Bettencourt PhD, et al.
Published: (2021-06-01)

Decoding Survival in Elderly Acute Myocardial Infarction: The Prognostic Interplay of B-Type Natriuretic Peptide, Ejection Fraction, and Renal Function – An Observational Study
by: Rajpal Prajapati, et al.
Published: (2025-04-01)

Association of LDL Cholesterol and hs-CRP with Subtypes of Heart Failure in Type 2 Diabetes Mellitus Patients: A Cross-sectional Study
by: Vineetha Naga Lakshmi Giduturi, et al.
Published: (2025-08-01)

Modern echocardiographic criteria for heart failure with preserved ejection fraction: not only diastolic dysfunction
by: O. M. Drapkina, et al.
Published: (2020-04-01)

Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register
by: I. V. Zhirov, et al.
Published: (2021-02-01)

Temporal left ventricular ejection fraction variations and outcomes in wide population of cardiovascular patients with and without heart failure
by: Radosław Szczerba, et al.
Published: (2025-03-01)

Survival after myocardial infarction according to left ventricular function and heart failure symptoms
by: Jarle Jortveit, et al.
Published: (2025-08-01)